Troy Noordenbos

1.3k citations
21 papers · 1.0k indexed · 1 hit paper · h-index 13
    • Spondyloarthritis Studies and Treatments 12
    • Rheumatoid Arthritis Research and Therapies 7
    • Urticaria and Related Conditions 3
  • Hematology top 5%
    • Autoimmune and Inflammatory Disorders Research 6
  • Immunology top 5%
    • Mast cells and histamine 5
    • Psoriasis: Treatment and Pathogenesis 5
    • IL-33, ST2, and ILC Pathways 3
    • CAR-T cell therapy research 2

Troy Noordenbos

20 papers receiving 1.0k citations

Hit Papers

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cel...93202420262025255075

Peers

Troy Noordenbos
Comparison fields: 5 of 72
  • Rheumatology 629
  • Hematology 321
  • Immunology 591
  • Dermatology 76
  • Immunology and Allergy 33
Replace B. Vitolo with:
B. Vitolo Italy
Ariane Hammitzsch Germany
Delphine Lemeiter France
Karl Staser United States
PP Tak Netherlands
Elisa Corsiero United Kingdom
N. Kaibara Japan
Kazuhisa Nozawa Japan
Hideyuki Shibuya Japan
Anette Knedla Germany
Troy Noordenbos relative to B. Vitolo Italy B. Vitolo's profile →
Citations per field
00.5×
B. Vitolo · 1×
Citations per year

Countries citing papers authored by Troy Noordenbos

Since Specialization
Citations

This map shows the geographic impact of Troy Noordenbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Noordenbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Noordenbos more than expected).

Fields of papers citing papers by Troy Noordenbos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy Noordenbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Noordenbos. The network helps show where Troy Noordenbos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Troy Noordenbos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Troy Noordenbos Line = papers co-authored together Troy Noordenbos links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapybreakdown →
202493
2 20243
3 201834
4 201828
5 201618
6 201667
7 20154
8 20142
9 20143
10 201396
11 201252
12 2012120
13 2011226
14 20111
15 20101
16 2009130
17 200938
18 200911
19 200859
20 200847

About Troy Noordenbos

Troy Noordenbos is a scholar working on Rheumatology, Hematology and Immunology, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (12 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Mast cells and histamine (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Urticaria and Related Conditions (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Rheumatology (629 citations), Hematology (321 citations) and Immunology (591 citations). Troy Noordenbos has collaborated with scholars based in Netherlands, Spain and United States. Frequent co-authors include Dominique Baeten, Paul P. Tak, Nataliya Yeremenko, Juan D. Cañete, Carmen A. Ambarus, Marleen van de Sande, Tineke Cantaert, Hulda S. Hreggvidsdottir, Bernard Vandooren and Iris C. Blijdorp. Their work appears in journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Journal of Leukocyte Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026